Alteral Therapeutics ApS
CVR 43730967 · Private limited company (ApS) · Active · Medium risk
Alteral Therapeutics ApS is a Private limited company (ApS), founded on , based in Allerød. The company is registered in the industry fremstilling af farmaceutiske præparater. Our model estimates a bankruptcy risk of 1.6% over the next 12 months, which is 1.1 times the average for Danish companies. 3 annual reports have been published, of which 1 more than six months after the end of the financial year. The latest annual report (31 Dec 2025) shows equity of DKK 979k and a net result of DKK 624k. CEO: Allan Traugott Wehnert.
Bankruptcy risk for Alteral Therapeutics ApS
1.1 × the average (1.41%) · higher risk than 79% of active Danish companies
Increases the risk
Reduces the risk
The factors show how often companies with the same characteristic went bankrupt compared with the average (“lift”). The risk is a statistical estimate from a model trained on 141,000+ Danish bankruptcies (AUC 0.93) – not a credit rating. Read about the method.
Company details
- CVR number
- 43730967
- Status
- Active
- Company type
- Private limited company (ApS)
- Founded
- (3 years)
- Address
- Bakkevej 41
3450 Allerød - Municipality
- Allerød
- Industry
- Fremstilling af farmaceutiske præparater (212000)
Bankruptcies in the industry: Fremstilling af farmaceutiske præparater - Share capital
- DKK 40k
- Audit opted out
- Yes
Warning signs
| Annual reports filed late | 1 of 3 |
| Missing annual report | No |
| Negative equity | No |
| Equity ratio | 93.9% |
| Current ratio | 1,599% |
| Moves (last 2 years) | 1 |
| CEO changes in total | 3 |
| CEO's previous bankruptcies | 1 |
| Other companies at the address | 1 |
| Going-concern uncertainty | No |
Financials and key figures
| Financial year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Gross profit | DKK -125k | – | – |
| Net profit | DKK 624k | DKK 20k | DKK 294k |
| Equity | DKK 979k | DKK 355k | DKK 334k |
| Total assets | DKK 1.0m | DKK 403k | DKK 416k |
| Cash | DKK 97k | DKK 17 | – |
| Short-term debt | DKK 64k | DKK 48k | – |
| Avg. employees | 0 | – | – |
Latest annual report: Reporting class B · auditor's statement: No assurance.
Filed annual reports
| Reporting period | Published | Days after period end | |
|---|---|---|---|
| 1 Jan 2025 – 31 Dec 2025 | 181 | ||
| 1 Jan 2024 – 31 Dec 2024 | 181 | ||
| 22 Dec 2022 – 31 Dec 2023 | 184 | Late |
The annual report must reach the Danish Business Authority no later than 5 months after the end of the financial year. We mark reports published more than 6 months after as “late”.
Management, owners and auditor
| Role | Name | From | To |
|---|---|---|---|
| CEO | Allan Traugott Wehnert | Current | |
| CEO | Allan Traugott Wehnert | ||
| CEO | Rasmus Christian Drewes Jensen | ||
| Owner (100%) | Wehnert Holding ApS | Current | |
| Owner (50%) | Drewes Jensen Holding ApS | ||
| Owner (50%) | Wehnert Holding ApS | ||
| Founder | Drewes Jensen Holding ApS | Current | |
| Founder | Wehnert Holding ApS | Current |
The CEOs' other companies
Allan Traugott Wehnert – 7 other companies, of which 1 bankrupt
- ANPARTSSELSKABET WEHNERT Bankrupt 6 May 1996
- BIO-CONVERT A/S Active
- NEUROINNOVATECH ApS Active
- NP Bioinnovation A/S Active
- Novithera ApS Active
- Orocidin A/S Active
- Wehnert Holding ApS Active
Rasmus Christian Drewes Jensen – 2 other companies
- Orocidin A/S Active
- Ydun ApS Active
Address history (3 moves)
| Bakkevej 41, 3450 Allerød | |
| c/o Firm Management ApS, Dyrehavevej 3B, 2930 Klampenborg | |
| Mesterlodden 3A, 1., 2820 Gentofte | |
| Gustav Webersvej 31, 3520 Farum |
Other companies at the same address
- Wehnert Holding ApS Active
Similar companies in Allerød
- OrfoNeuro ApS Lynge
- Scanleaf ApS Allerød
Questions and answers about Alteral Therapeutics ApS
Has Alteral Therapeutics ApS gone bankrupt?
No, Alteral Therapeutics ApS is not registered as bankrupt in the CVR register. Its status is: active.
What is the bankruptcy risk of Alteral Therapeutics ApS?
Our model estimates a bankruptcy risk of 1.6% over the next 12 months (medium risk), which is 1.1 times the average for Danish companies.
Who is the CEO of Alteral Therapeutics ApS?
Allan Traugott Wehnert is the CEO of Alteral Therapeutics ApS.
When was Alteral Therapeutics ApS founded?
Alteral Therapeutics ApS was founded on 22 December 2022.
What is the equity of Alteral Therapeutics ApS?
Equity was DKK 979k according to the annual report for the period ending 31 December 2025.
Source: the CVR register and annual reports published by the Danish Business Authority. The information is updated continuously.